{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:15:21Z","timestamp":1781212521804,"version":"3.54.1"},"reference-count":50,"publisher":"Informa UK Limited","issue":"3","funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2026,3,16]]},"DOI":"10.1080\/14737167.2026.2615680","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:35:16Z","timestamp":1767947716000},"page":"361-368","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Cost of rimegepant and lasmiditan associated adverse events, for acute treatment in migraine in Spain"],"prefix":"10.1080","volume":"26","author":[{"given":"Sonia","family":"Santos-Lasaosa","sequence":"first","affiliation":[{"name":"Universidad de Zaragoza","place":["Zaragoza, Spain"]},{"name":"Aragon Institute for Health Research (IIS Arag\u00f3n)","place":["Zaragoza, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Armada","sequence":"additional","affiliation":[{"name":"Pfizer, S.L.U","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Moya-Alarc\u00f3n","sequence":"additional","affiliation":[{"name":"Pfizer, S.L.U","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dar\u00edo","family":"Rubio-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Health Value, S.L","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rubio-Terr\u00e9s","sequence":"additional","affiliation":[{"name":"Health Value, S.L","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Irimia","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Universidad de Navarra","place":["Pamplona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30322-3"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-02192-z"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01740-3"},{"key":"e_1_3_8_7_1","unstructured":"Sociedad Espa\u00f1ola de Neurolog\u00eda. Manual de Pr\u00e1ctica Cl\u00ednica en Cefaleas. Recomendaciones diagn\u00f3stico-terap\u00e9uticas de la Sociedad Espa\u00f1ola de Neurolog\u00eda en 2020. SEN; [2020 dic 18]."},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241252666"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413480756"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2002.00404.x"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024221143773"},{"key":"e_1_3_8_12_1","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use. European public assessment report Vydura (rimegepant) (EMA\/CHMP\/172260\/2022). [cited 2025 May 4]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/vydura-epar-public-assessment-report_en.pdf."},{"key":"e_1_3_8_13_1","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use. European public assessment report rayvow (lasmiditan) (EMA\/622555\/2022). [cited 2025 May 04] Available from: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/rayvow-epar-public-assessmentreport_en.pdf."},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01502-z"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.315991"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.7939"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28544"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000001072"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01440-w"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231151419"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01723-4"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.2174\/0118715273304677240529062909"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2020.1768850"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080107"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.08.1265"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-011-0683-0"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S121093"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2018.05.003"},{"key":"e_1_3_8_29_1","unstructured":"Orden 727\/2017 de 7 de agosto del Consejero de Sanidad por la que se fijan los precios p\u00fablicos por la prestaci\u00f3n de los servicios y actividades de naturaleza sanitaria de la red de centros de la Comunidad de Madrid. BOCM No\u0320 198. 2017 ago 21."},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.avdiab.2012.10.006"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2012.06.014"},{"key":"e_1_3_8_32_1","volume-title":"Presented at the 18th European Headache Congress","author":"Rogula B","year":"2024","unstructured":"Rogula B, de Br\u00fan C, Powell L, et al. Long-term safety and discontinuation for rimegepant versus lasmiditan in the acute treatment of migraine: a matching-adjusted indirect comparison (poster P105). In: Presented at the 18th European Headache Congress; Rotterdam, The Netherlands; 2024 Dec 4\u20137."},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413500727"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31606-X"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811090"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00126-6"},{"key":"e_1_3_8_37_1","unstructured":"NCT03235479. Safety and efficacy study in adult subjects with acute migraines. [cited 2024 Oct 8]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03235479"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241232944"},{"key":"e_1_3_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70047-9"},{"key":"e_1_3_8_40_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006641"},{"key":"e_1_3_8_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz134"},{"key":"e_1_3_8_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/2515816320958176"},{"key":"e_1_3_8_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14122"},{"key":"e_1_3_8_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102421989232"},{"key":"e_1_3_8_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-02172-3"},{"key":"e_1_3_8_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00390-1"},{"key":"e_1_3_8_47_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1431562"},{"key":"e_1_3_8_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01935-8"},{"key":"e_1_3_8_49_1","unstructured":"Cooper WM. 5-HT1F agonist toxicity profile and role in paradigm. Expert perspectives: advances in the management of acute migraine: episode 8. [cited 2024 Dec 10]. Available from: https:\/\/www.neurologylive.com\/view\/5-ht1f-agonist-toxicity-profile-and-role-in-paradigm"},{"key":"e_1_3_8_50_1","unstructured":"National Cancer Institute. Instructions and guidelines. Version 3.0 release 4. 2008 Jan 15 [cited 2020 Apr 28]. access: 10\/12\/2024. Available from: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/cdus_ig_3r4.pdf"},{"key":"e_1_3_8_51_1","unstructured":"The use of the WHO-UMC system for standardized case causality assessment. The Uppsala Monitoring Centre. [cited 2025 Aug 19]. Available from: https:\/\/www.who.int\/docs\/default-source\/medicines\/pharmacovigilance\/whocausality-assessment.pdf"},{"key":"e_1_3_8_52_1","doi-asserted-by":"publisher","DOI":"10.61679\/1404794805"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2615680","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:44:59Z","timestamp":1773661499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2026.2615680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,16]]}},"alternative-id":["10.1080\/14737167.2026.2615680"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2026.2615680","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}